Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNewRiver Regulatory News (NRR)

Share Price Information for NewRiver (NRR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 75.10
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (0.134%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 75.10
NRR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

24 May 2024 09:08

RNS Number : 8353P
Liberum Capital Limited
24 May 2024
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NewRiver REIT plc

(c) Name of the party to the offer with which exempt principal trader is connected:

NewRiver REIT plc

(d) Date dealing undertaken:

23rd May 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1P

 

 

Purchase

 

8,000

 

0.7389

 

0.7389

 

ORD 1P

 

 

Sale

 

 

3,661

 

0.744

 

0.742

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

24th May 2024

Contact name:

Shivani Ghiraiya

Telephone number:

020 3100 2213

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGIGDURGDDGSS
Date   Source Headline
30th Jun 202312:41 pmRNSDirector/PDMR Shareholding
30th Jun 202312:38 pmRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSFinal disposals within Napier 50/50 Joint Venture
27th Jun 20233:30 pmRNSAnnual Report and Accounts and AGM 2023
22nd Jun 20239:00 amRNSScrip Dividend Reference Price
8th Jun 20231:54 pmRNSDividend Declaration
6th Jun 20237:00 amRNSNewRiver REIT PLC Full Year Results
26th May 20239:00 amRNSNotice of Results
22nd May 20233:16 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ4 Company Update
3rd Feb 20233:46 pmRNSTotal Voting Rights
19th Jan 20237:00 amRNSQ3 Company Update
11th Jan 20239:00 amRNSScrip dividend share allotment
15th Dec 202212:05 pmRNSScrip Dividend Reference Price
13th Dec 20227:00 amRNSFitch Affirms NewRiver REIT plc’s Credit Ratings
9th Dec 202211:27 amRNSHolding(s) in Company
1st Dec 20225:28 pmRNSDirector Declaration
1st Dec 20223:00 pmRNSTotal Voting Rights
1st Dec 20222:05 pmRNSDividend Declaration
29th Nov 20224:02 pmRNSDirector/PDMR Shareholding
28th Nov 20223:28 pmRNSHolding(s) in Company
24th Nov 20227:00 amRNSNewRiver REIT plc Half Year Results
17th Nov 20227:00 amRNSNew operational management agreement
8th Nov 20227:00 amRNSNotice of Half Year Results
5th Sep 20223:04 pmRNSDirector/PDMR Shareholding
1st Sep 202212:18 pmRNSTotal Voting Rights
25th Aug 20223:52 pmRNSScrip dividend share allotment
9th Aug 20223:58 pmRNSHolding(s) in Company
4th Aug 20222:07 pmRNSScrip Dividend Reference Price
1st Aug 20225:13 pmRNSTotal Voting Rights
26th Jul 20224:32 pmRNSResult of AGM
26th Jul 20227:00 amRNSFirst Quarter Company Update
21st Jul 20227:00 amRNSDividend Declaration
7th Jul 20223:47 pmRNSChange of Registered Office
7th Jul 20223:45 pmRNSDirector/PDMR Shareholding
1st Jul 20222:43 pmRNSNewRiver REIT plc Total Voting Rights
24th Jun 20223:32 pmRNSNewRiver Annual Report and Accounts and AGM 2022
7th Jun 20222:47 pmRNSDirector/PDMR Shareholding
7th Jun 20227:00 amRNSNewRiver REIT plc FY22 Full Year Results
31st May 20227:00 amRNSAppointment of Non-Executive Director
24th May 20227:00 amRNSNotice of Full Year Results
17th May 202212:27 pmRNSHolding(s) in Company
6th May 20228:59 amRNSHolding(s) in Company
21st Apr 20227:00 amRNSTrading Update - Return to Capital Growth in H2
1st Apr 20227:00 amRNSDisposal of Templars Square Shopping Centre
8th Mar 202210:09 amRNSHolding(s) in Company
1st Mar 20223:57 pmRNSTotal Voting Rights
21st Feb 202212:30 pmRNSDirector/PDMR Shareholding
11th Feb 20221:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.